drugset / Trial / NCT07008222

Pain Related to Local Anesthetic Administration for Nexplanon Placement

NCT07008222

Not yet recruiting 68 enrolled University of California, San Diego
RandomizedParallel-groupTriple-blindOther

Summary

This research study is being conducted to see if using buffered lidocaine for Nexplanon placement decreases pain associated with administering local anesthesia compared to unbuffered lidocaine, which is currently used in clinic. Lidocaine is used to stop pain in the nerve fibers in order to decrease pain at the time of the procedure. We want to find out if using buffered lidocaine will decrease discomfort at the time of receiving local anesthesia for Nexplanon insertion.

Timeline

Start
2025-06
Primary completion
2026-01
Completion
2026-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2.7 ml
Subject Lidocaine Other / unclassified 3 ml
Background sodium bicarbonate Diagnostic / imaging agent 0.3 ml

Indications

No indication recorded.